Compare NMTC & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NMTC | COSM |
|---|---|---|
| Founded | 2009 | 2009 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.2M | 33.8M |
| IPO Year | 2010 | 2009 |
| Metric | NMTC | COSM |
|---|---|---|
| Price | $1.07 | $0.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.27 | N/A |
| AVG Volume (30 Days) | 148.8K | ★ 3.6M |
| Earning Date | 08-13-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.43 | 46.15 |
| EPS | N/A | ★ N/A |
| Revenue | $9,097,692.00 | ★ $65,271,815.00 |
| Revenue This Year | N/A | $23.79 |
| Revenue Next Year | $26.57 | $58.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 163.47 | 19.93 |
| 52 Week Low | $0.61 | $0.16 |
| 52 Week High | $12.24 | $1.24 |
| Indicator | NMTC | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 33.72 | 60.41 |
| Support Level | $0.96 | $0.35 |
| Resistance Level | $1.35 | $0.41 |
| Average True Range (ATR) | 0.11 | 0.04 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 27.26 | 62.06 |
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.